imipenem - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial
AUST R: 10509
Active ingredients:
cilastatin
imipenem

Dosage form:
Injection, powder for

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800818553

Deletion from market:
29 Feb 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An imipenem/cilastatin injection product may be available via the Special Access Scheme (SAS): https://www.tga.gov.au/products/prescribe-unapproved-therapeutic-good-health-practitioners